Literature DB >> 23717819

A kit to facilitate and standardize the processing of sputum for measurement of airway inflammation.

Simone Chaboillez1, Angira Dasgupta, Philippe Prince, Louis-Philippe Boulet, Catherine Lemière.   

Abstract

BACKGROUND: The use of inflammometry has been shown to be effective for managing asthma. However, sputum processing can be time consuming. Furthermore, methods of sputum processing can vary among facilities. To help with standardization and to simplify the procedure for laboratory staff, a novel, commercially available processing device (Accufilter, Cellometrics Inc, Canada) has been developed.
OBJECTIVE: To assess the validity of the Accufilter device and kit for recovery of treated specimens, and for quantitative sputum inflammatory cell counts by comparing intrasample measurements with those using the same procedure without the Accufilter device and kit.
METHODS: The present study was a wet laboratory comparison of induced sputum cell counts obtained from sputum processed with versus without the device and kit. Comparisons of each sputum specimen were performed by the same technologist in random order.
RESULTS: A total of 39 samples were processed using both the standard method and the Accufilter device. The intraclass correlation coefficients were high for the weight of the filtrate, and for eosinophil and neutrophil differential counts.
CONCLUSION: A good degree of agreement of results was apparent when the two methods were compared. The differences noted between both methods were minimal and did not modify clinical interpretation. The use of the Accufilter device and kit can be used in place of the standard method for sputum quantitative analysis, especially in centres with large sample loads.

Entities:  

Mesh:

Year:  2013        PMID: 23717819      PMCID: PMC3956330          DOI: 10.1155/2013/591316

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  17 in total

1.  An effective strategy for diagnosing occupational asthma: use of induced sputum.

Authors:  Frédéric Girard; Simone Chaboillez; André Cartier; Johanne Côté; Frederick E Hargreave; Manon Labrecque; Jean-Luc Malo; Susan M Tarlo; Catherine Lemière
Journal:  Am J Respir Crit Care Med       Date:  2004-07-21       Impact factor: 21.405

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.

Authors:  L Jayaram; M M Pizzichini; R J Cook; L-P Boulet; C Lemière; E Pizzichini; A Cartier; P Hussack; C H Goldsmith; M Laviolette; K Parameswaran; F E Hargreave
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

4.  The evaluation of a cell dispersion method of sputum examination.

Authors:  T Popov; R Gottschalk; R Kolendowicz; J Dolovich; P Powers; F E Hargreave
Journal:  Clin Exp Allergy       Date:  1994-08       Impact factor: 5.018

5.  Diagnosing occupational asthma: use of induced sputum.

Authors:  C Lemière; M M Pizzichini; R Balkissoon; L Clelland; A Efthimiadis; D O'Shaughnessy; J Dolovich; F E Hargreave
Journal:  Eur Respir J       Date:  1999-03       Impact factor: 16.671

6.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.

Authors:  E Pizzichini; M M Pizzichini; A Efthimiadis; S Evans; M M Morris; D Squillace; G J Gleich; J Dolovich; F E Hargreave
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

7.  Measuring bronchitis in airway diseases: clinical implementation and application: Airway hyperresponsiveness in asthma: its measurement and clinical significance.

Authors:  Parameswaran Nair; Frederick E Hargreave
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

8.  Airways disease: phenotyping heterogeneity using measures of airway inflammation.

Authors:  Salman Siddiqui; Christopher E Brightling
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

9.  Use of induced sputum cell counts to investigate airway inflammation in asthma.

Authors:  I Pin; P G Gibson; R Kolendowicz; A Girgis-Gabardo; J A Denburg; F E Hargreave; J Dolovich
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

10.  Mepolizumab and exacerbations of refractory eosinophilic asthma.

Authors:  Pranabashis Haldar; Christopher E Brightling; Beverley Hargadon; Sumit Gupta; William Monteiro; Ana Sousa; Richard P Marshall; Peter Bradding; Ruth H Green; Andrew J Wardlaw; Ian D Pavord
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

View more
  3 in total

1.  The evolution of sputum cytometry to assess bronchitis.

Authors:  Hui Fang Lim; Parameswaran Nair
Journal:  Can Respir J       Date:  2013 Nov-Dec       Impact factor: 2.409

2.  Reliability of a rapid hematology stain for sputum cytology.

Authors:  Jéssica Gonçalves; Emilio Pizzichini; Marcia Margaret Menezes Pizzichini; Leila John Marques Steidle; Cristiane Cinara Rocha; Samira Cardoso Ferreira; Célia Tânia Zimmermann
Journal:  J Bras Pneumol       Date:  2014 May-Jun       Impact factor: 2.624

Review 3.  Update on clinical inflammometry for the management of airway diseases.

Authors:  Parameswaran Nair
Journal:  Can Respir J       Date:  2013 Mar-Apr       Impact factor: 2.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.